{rfName}
Ep

Indexado en

Licencia y uso

Citaciones

Altmetrics

Análisis de autorías institucional

Compartir

Publicaciones
>
Artículo pendiente de publicación

Epidemiology of major and minor relapses in giant cell arteritis according to EULAR definitions: insights from the ARTESER registry.

Publicado en:Rheumatology (Oxford, England). (): - - 2025-05-09 (), DOI: 10.1093/rheumatology/keaf237

Autores: Narváez J; Domínguez-Álvaro M; Hernández-Rodríguez I; de Miguel E; Silva-Díaz M; Belzunegui JM; Moriano C; Sánchez-Martín J; Lluch J; Calvo I; Aldasoro V; Abasolo L; Loricera J; Garrido N; Castañeda S; Vasques-Rocha M; Iñiguez CL; Hernández-Hernández V; Campos-Fernández C; Alcalde-Villar M; Juan-Mas A; Blanco R

Afiliaciones

- Autor o Coautor
Department of Rheumatology, Complejo Hospitalario de Navarra., Pamplona, Spain. - Autor o Coautor
Department of Rheumatology, Complejo Hospitalario Universitario de A Coruña, La Coruña, Spain. - Autor o Coautor
Department of Rheumatology, Complejo Hospitalario Universitario de Vigo, Vigo, Spain. - Autor o Coautor
Department of Rheumatology, Consorci Hospital General Universitari de Valencia. Valencia, Spain. - Autor o Coautor
Department of Rheumatology, Hospital Clínico San Carlos. Instituto de Investigación Sanitaria San Carlos (IdISSC), Madrid, Spain. - Autor o Coautor
Department of Rheumatology, Hospital Universitario Marqués de Valdecilla- Immunopathology Group-IDIVAL, Santander, Spain. - Autor o Coautor
Department of Rheumatology. Department of Rheumatology. Hospital, Universitario de Canarias. Santa Cruz de Tenerife, Spain. - Autor o Coautor
Department of Rheumatology., Hospital Universitari Son Llàtzer. Palma de Mallorca, Spain. - Autor o Coautor
Department of Rheumatology., Hospital Universitario 12 de octubre, Madrid, Spain. - Autor o Coautor
Department of Rheumatology., Hospital Universitario Araba, Vitoria-Gasteiz, Spain. - Autor o Coautor
Department of Rheumatology., Hospital Universitario de Basurto, Bilbao, Spain. - Autor o Coautor
Department of Rheumatology., Hospital Universitario de Bellvitge. Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain. - Autor o Coautor
Department of Rheumatology., Hospital Universitario de Bellvitge., Barcelona. - Autor o Coautor
Department of Rheumatology., Hospital Universitario de La Princesa. IIS-Princesa, cátedra UAM-Roche, Universidad Autónoma de Madrid, Madrid, Spain. - Autor o Coautor
Department of Rheumatology., Hospital Universitario de León. León, Spain. - Autor o Coautor
Department of Rheumatology., Hospital Universitario Donosti, San Sebastián, Spain. - Autor o Coautor
Department of Rheumatology., Hospital Universitario La Paz, Madrid, Spain. - Autor o Coautor
Department of Rheumatology., Hospital Universitario Marqués de Valdecilla- Immunopathology Group-IDIVAL, Santander, Spain. - Autor o Coautor
Department of Rheumatology., Hospital Universitario Severo Ochoa Leganes, Madrid, Spain. - Autor o Coautor
Department of Rheumatology., Hospital Universitario Virgen del Rocío, Sevilla, Spain. - Autor o Coautor
Department of Rheumatology., Hospital, Universitario Lucus Augusti, Lugo, Spain. - Autor o Coautor
Research Unit Sociedad Española de Reumatología, Madrid, Spain. - Autor o Coautor
Ver más

Resumen

To investigate the prevalence, timing, and risk factors at diagnosis associated with relapses in giant cell arteritis (GCA), with a separate analysis of major and minor relapses. A retrospective review of patients from the Spanish multicentre GCA registry (ARTESER) was conducted. Relapses were classified using 2018 EULAR definitions. We included 1,284 patients with at least one year of follow-up. Twenty-six percent experienced relapses, with cumulative rates of 18.1%, 27.9%, 37.6%, and 44.8% at 1, 2, 3, and 4 years, respectively. Multiple relapses were observed in 14.6% of patients during the first year, 10.5% in the second, 9% in the third, and 17.8% in the fourth, reflecting the relapsing-remitting nature of GCA. According to EULAR definitions, major relapses represented 26.7% of all recorded relapses and affected 7.6% of patients.Younger age at diagnosis (HR: 0.976, p= 0.004) and a higher total dose of prednisone at the first relapse (HR: 0.998, p= 0.003) were associated with a reduced risk of overall relapses. Severe ischemic complications (HR: 4.126, p< 0.001) and large-vessel (LV) involvement at diagnosis (HR: 1.992, p= 0.024) significantly increased the risk of major relapses, while younger age (HR: 0.970, p= 0.002) was protective against minor relapses. Major relapses are not so uncommon, representing a quarter of all relapses. The presence of severe ischemic complications and LV involvement at diagnosis substantially increase their risk.

Palabras clave

Indicios de calidad

Impacto y visibilidad social

Desde la dimensión de Influencia o adopción social, y tomando como base las métricas asociadas a las menciones e interacciones proporcionadas por agencias especializadas en el cálculo de las denominadas “Métricas Alternativas o Sociales”, podemos destacar a fecha 2025-06-30:

Con una intencionalidad más de divulgación y orientada a audiencias más generales podemos observar otras puntuaciones más globales como:

  • El Score total de Altmetric: 0.5.
  • El número de menciones en la red social X (antes Twitter): 1 (Altmetric).